These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 4435008)

  • 41. The uptake of tritiated delta 1-tetrahydrocannabinol by the isolated vas deferens of the rat.
    Egan SM; Graham JD; Lewis MJ
    Br J Pharmacol; 1976 Apr; 56(4):413-6. PubMed ID: 1260220
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Morphine binding to human plasma proteins.
    Olsen GD
    Clin Pharmacol Ther; 1975 Jan; 17(1):31-5. PubMed ID: 47279
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Perfusion of the isolated rat brain with [14C]-delta1-tetrahydrocannabinol.
    Martin B; Agurell S; Krieglstein J; Rieger H
    Biochem Pharmacol; 1977 Dec; 26(23):2307-9. PubMed ID: 588312
    [No Abstract]   [Full Text] [Related]  

  • 44. 11-hydroxy- 9 -tetrahydrocannabinol: pharmacology, disposition, and metabolism of a major metabolite of marihuana in man.
    Lemberger L; Crabtree RE; Rowe HM
    Science; 1972 Jul; 177(4043):62-4. PubMed ID: 5041775
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Whole-body autoradiography of the pregnant mouse after administration of 14 C- 9 -THC.
    Kennedy JS; Waddell WJ
    Toxicol Appl Pharmacol; 1972 Jun; 22(2):252-8. PubMed ID: 5048055
    [No Abstract]   [Full Text] [Related]  

  • 46. Urinary excretion half-life of delta 1-tetrahydrocannabinol-7-oic acid in heavy marijuana users after smoking.
    Johansson E; Halldin MM
    J Anal Toxicol; 1989; 13(4):218-23. PubMed ID: 2550702
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of cannabinoid concentrations in oral fluid and whole blood between occasional and regular cannabis smokers prior to and after smoking a cannabis joint.
    Fabritius M; Chtioui H; Battistella G; Annoni JM; Dao K; Favrat B; Fornari E; Lauer E; Maeder P; Giroud C
    Anal Bioanal Chem; 2013 Dec; 405(30):9791-803. PubMed ID: 24202191
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Studies on butylmalonic acidmono-(1,2-diphenylhydrazide)-calcium (bumadizone-calcium) labelled with 14C. Metabolism and kinetics].
    Ludwig G; Ache IM
    Arzneimittelforschung; 1973 Sep; 23(9):1226-31. PubMed ID: 4801214
    [No Abstract]   [Full Text] [Related]  

  • 49. Pharmacokinetic properties of delta9-tetrahydrocannabinol in serum and oral fluid.
    Kauert GF; Ramaekers JG; Schneider E; Moeller MR; Toennes SW
    J Anal Toxicol; 2007 Jun; 31(5):288-93. PubMed ID: 17579974
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Absorption, distribution, metabolism and excretion of [14C]ebastine after a single administration in rats.
    Fujii T; Matsumoto S; Amejima H; Hatoyama T; Nakao M; Kagemoto A; Tanaka K; Miyazaki H
    Arzneimittelforschung; 1994 Apr; 44(4):527-38. PubMed ID: 7912071
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The fate of 2,4,5-trichlorophenoxyacetic acid (2,4,5-T) following oral administration to rats and dogs.
    Piper WN; Rose JQ; Leng ML; Gehring PJ
    Toxicol Appl Pharmacol; 1973 Nov; 26(3):339-51. PubMed ID: 4767573
    [No Abstract]   [Full Text] [Related]  

  • 52. Kinetics of diphenylhydantoin in uraemic patients: consequences of decreased plasma protein binding.
    Odar-Cederlöf I; Borgå O
    Eur J Clin Pharmacol; 1974; 7(1):31-7. PubMed ID: 4852619
    [No Abstract]   [Full Text] [Related]  

  • 53. (-)- s -tetrahydrocannabinol: two novel in vitro metabolites.
    Maynard DE; Gurny O; Pitcher RG; Kierstead RW
    Experientia; 1971 Oct; 27(10):1154-5. PubMed ID: 5127857
    [No Abstract]   [Full Text] [Related]  

  • 54. Structure-activity relationships in man of cannabis constituents, and homologs and metabolites of delta9-tetrahydrocannabinol.
    Hollister LE
    Pharmacology; 1974; 11(1):3-11. PubMed ID: 4610598
    [No Abstract]   [Full Text] [Related]  

  • 55. [Pharmacokinetic studies on 14C-azapropazone dihydrate in the rat].
    Klatt L; Koss FW
    Arzneimittelforschung; 1973 Jul; 23(7):913-9. PubMed ID: 4800443
    [No Abstract]   [Full Text] [Related]  

  • 56. [Binding of delta-8-THC to human serum proteins: binding as a function of lipoprotein composition].
    Capelle N; Treich I; Ayrault-Jarrier M; Hoellinger H; Scherrmann JM
    Eur J Toxicol Environ Hyg; 1976; 9(1):5-9. PubMed ID: 176039
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacologic effects and physiologic disposition of delta 6a,10a dimethyl heptyl tetrahydrocannabinol (DMHP) in man.
    Lemberger L; McMahon R; Archer R; Matsumoto K; Rowe H
    Clin Pharmacol Ther; 1974 Apr; 15(4):380-6. PubMed ID: 4821441
    [No Abstract]   [Full Text] [Related]  

  • 58. Picogram analysis of tetrahydrocannabinol and application to biological fluids.
    Garrett ER; Hunt CA
    J Pharm Sci; 1973 Jul; 62(7):1211-4. PubMed ID: 4714142
    [No Abstract]   [Full Text] [Related]  

  • 59. Metabolism and disposition of methylphenidate-14C: studies in man and animals.
    Faraj BA; Israili ZH; Perel JM; Jenkins ML; Holtzman SG; Cucinell SA; Dayton PG
    J Pharmacol Exp Ther; 1974 Dec; 191(3):535-47. PubMed ID: 4473537
    [No Abstract]   [Full Text] [Related]  

  • 60. Physiologic disposition of nabilone, a cannabinol derivative, in man.
    Rubin A; Lemberger L; Warrick P; Crabtree RE; Sullivan H; Rowe H; Obermeyer BD
    Clin Pharmacol Ther; 1977 Jul; 22(1):85-91. PubMed ID: 872500
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.